ArticleWorld journal of gastroenterology2008
State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008.
Article in World journal of gastroenterology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparison between the Effects of Acupuncture Relative to Other Controls on Irritable Bowel Syndrome: A Meta-Analysis.Pain research & management · 2019Pooled it
- Trial
- Relationship Between Sensitivity to Disgust and Irritable Bowel Syndrome: A Study on Healthy Individuals.Clinical neuropsychiatry · 2022Article
- Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic Review.Evidence-based complementary and alternative medicine : eCAM · 2021Review
- Efficacy and Safety of Acupoint Catgut Embedding for Diarrhea-Predominant Irritable Bowel Syndrome and Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.Evidence-based complementary and alternative medicine : eCAM · 2020Review
- Self-Perception of Iranian Patients during their life with Irritable Bowel Syndrome: A Qualitative Study.Electronic physician · 2017Article
- Moxibustion for Diarrhea-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Evidence-based complementary and alternative medicine : eCAM · 2016Review
- A new acupuncture method for management of irritable bowel syndrome: A randomized double blind clinical trial.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2014Article
- Complementary and alternative medicines in irritable bowel syndrome: an integrative view.World journal of gastroenterology · 2014Review
- The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases.International journal of general medicine · 2014Review
- Impact of shiftwork on irritable bowel syndrome and functional dyspepsia.Journal of Korean medical science · 2013Article
- The role of N-acetyltransferase 2 polymorphism in the etiopathogenesis of inflammatory bowel disease.Digestive diseases and sciences · 2011Article
- Preoperative risk evaluation of postoperative morbidity in IBD patients--impact of the POSSUM score.International journal of colorectal disease · 2011Article
- Article
- Mitogen activated protein kinases: a role in inflammatory bowel disease?Clinical and experimental immunology · 2009Review
- Complementary and alternative medicine for treatment of irritable bowel syndrome.Canadian family physician Medecin de famille canadien · 2009Review
- Dietary modulation of inflammation-induced colorectal cancer through PPARγ.PPAR research · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are two of the leading causes of chronic intestinal conditions in the world. This issue of World Journal of Gastroenterology (WJG) presents a series of papers from world experts who discuss the current knowledge and opinions on these important conditions. Although great strides have been made in the diagnosis, treatment and pathology of IBS and IBD; much has yet to be explained. The etiologies and risk factors of these multifactorial conditions remain elusive. Specific diagnostic biomarkers need to be developed and safer treatments developed. The burden of IBS and IBD on the healthcare system is felt with repeated medical care visits and high costs. IBS and IBD patients can account for 30%-50% of office visits at gastroenterology services/clinics. Over one million people have IBD in the United States, with 30000 new cases being diagnosed every year. One-quarter million people in the UK are afflicted with IBD. The cost of medical care in the United States for IBD is estimated to be 1.8 billion dollars/year.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.